Post-column infusion is a qualitative LC-MS experiment that shows where in a chromatographic run co-eluting matrix components suppress or enhance ionization. A constant stream of analyte is teed into the column effluent while an extracted blank matrix is injected, and dips or rises in the otherwise steady signal mark the affected retention times.
It is one of the two standard matrix-effect experiments described in the LC-MS ion suppression and matrix effects guide: infusion tells you where an effect occurs, and the post-extraction spike tells you how large it is. This page covers how to set the experiment up, how to read the trace, what the trace cannot tell you and how to act on it.
How does post-column infusion work in LC-MS?
The technique was introduced by Bonfiglio and co-workers, who built a post-column infusion system to study electrospray ionization (ESI) suppression caused by endogenous plasma components and used it to compare extraction procedures; acetonitrile protein precipitation extracts produced the most suppression and methyl tert-butyl ether liquid–liquid extracts the least in their comparison.1 A syringe pump delivers the analyte solution through a tee between the column outlet and the ion source. With no matrix effect the infused analyte gives a constant signal; when a compound that suppresses or enhances ionization elutes from the column, that signal falls or rises for as long as the compound is in the source.2
In ESI of biological extracts the main cause of suppression appears to be a change in droplet solution properties caused by nonvolatile solutes, rather than gas-phase reactions that strip charge from the analyte.3 The infusion trace does not identify those solutes. It records their net effect on the one ion you are monitoring, as a function of retention time. That is why the experiment answers a location question and not a magnitude question: it confirms the presence or absence of suppression or enhancement at each point in the run, but it does not give a quantitative matrix effect.4
LC-MS PK Peak Integrity Engine
Interrogate carryover, matrix effects, ion suppression, and integration integrity before your PK data goes to QC.
How do you set up a post-column infusion experiment?
The setup needs one extra pump, one tee and two injections under the method’s own chromatographic conditions. Table 1 lists the elements and why each matters.
| Element | Typical choice | Why it matters |
|---|---|---|
| Infused compound | The analyte itself, or a compound with similar physicochemical properties | The matrix effect is compound-dependent; a dissimilar compound maps a different effect5 |
| Delivery | Syringe pump (or auxiliary pump) into a tee after the column | Adds analyte at a constant rate without passing it through the column2 |
| Infusion flow | Small relative to the column flow (10 µL/min into 0.4 mL/min in one published protocol) | Keeps the method’s own mobile-phase composition at the source5 |
| Infusion concentration | As a working rule, enough for a steady, on-scale signal well above noise | A dip can only be read if the baseline is stable and not saturated |
| Injection 1 | Solvent blank, same volume, same gradient | Reference trace: what the infused signal does with no matrix present4 |
| Injection 2 | Extracted blank matrix, prepared exactly as samples are | Shows where the extract’s co-eluting components change the signal4 |
| Acquisition | The analyte’s multiple reaction monitoring (MRM) transition across the whole run | The map must cover every retention time an analyte or internal standard can occupy |
The tee dilutes the infusion solution by the ratio of the combined flow to the infusion flow:
csource = csyringe × Finf / (Fcol + Finf)
where csyringe is the concentration in the syringe, Finf the infusion flow and Fcol the column flow. For the published example of 10 µL/min into 0.4 mL/min (400 µL/min):
10 / (400 + 10) = 10 / 410 = 0.0244, a 41-fold dilution
so a 100 ng/mL infusion solution reaches the source at 100 / 41 ≈ 2.44 ng/mL, and the infusion adds 2.4% to the flow entering the source. In practice the run order is:
- Start the infusion and wait until the analyte signal is stable.
- Inject the solvent blank and record the full gradient.
- Inject the extracted blank matrix and record the full gradient under identical conditions.
- Overlay the two traces and mark each analyte’s and internal standard’s retention window.
How do you read a post-column infusion trace?
Compare the matrix trace with the solvent trace point by point. Where the two agree within the precision of the MS signal there is no detectable effect; where the matrix trace falls there is suppression, and where it rises there is enhancement.4 Dividing one trace by the other gives a response ratio that removes any change in the infused signal common to both injections:
R(t) = 100% × Imatrix(t) / Isolvent(t)
where Imatrix(t) and Isolvent(t) are the infused-analyte signals at time t during the blank-matrix and solvent injections. Figure 1 shows the reading on conceptual traces.
The value that matters is R across each analyte’s elution window, not the depth of the deepest dip in the run. In Figure 1 the deepest dip reaches 20% near 0.75 min, but no analyte elutes there. Analyte 1 at 2.10 min reads 46%, which puts it inside a suppression region; Analyte 2 at 3.60 min reads 100%; Analyte 3 at 4.90 min reads 122%, so it would read high rather than low. These figures are illustrative calculations from the plotted traces. Table 2 summarizes the patterns and what each suggests.
| Pattern at the analyte window | What it suggests | Next step |
|---|---|---|
| Matrix trace matches the solvent trace | No detectable effect for this lot and this compound | Confirm with post-extraction spikes across lots before relying on it |
| Dip overlapping the window | Ion suppression at the analyte’s retention time | Move the analyte or remove the material, then acquire the map again |
| Rise overlapping the window | Ion enhancement at the analyte’s retention time | Treat as for a dip: results will read high, not low |
| Dip or rise elsewhere in the run | No effect on this analyte under these conditions | Check the internal standard’s and other analytes’ windows |
| Dip at the analyte window but not at the internal standard’s window | Analyte and internal standard experience different effects | Improve co-elution before relying on the ratio to correct |
What can post-column infusion not tell you?
An infusion trace is a location map, and four limits follow from how it is made. It is not quantitative: it confirms presence or absence of an effect but does not measure its size.4 It describes one infused compound, and the effect is compound-dependent, which is why the infused standard should resemble the analyte.5 It describes one extracted lot, so it says nothing about variation between lots or individual samples. And it describes one chromatographic condition: change the column, gradient or extraction and the map has to be acquired again.
The quantitative complement is the post-extraction spike design of Matuszewski and co-workers, which compares analyte response in neat solution, in extracted blank matrix spiked after extraction and in matrix spiked before extraction, so that matrix effect and recovery are measured separately (Matuszewski et al., 2003).6 In regulated bioanalysis, ICH M10 section 3.2.3 evaluates the matrix effect with at least three replicates of low and high quality-control (QC) samples, each prepared in matrix from at least six sources or lots, with accuracy within ±15% of nominal and precision no greater than 15% coefficient of variation (CV) for each lot.7 Table 3 sets the two experiments side by side.
| Question | Post-column infusion | Post-extraction spike |
|---|---|---|
| What it answers | Where in the run ionization changes | How large the effect is at the analyte’s retention time |
| Output | A continuous trace across the gradient | A response ratio (matrix factor) per lot and level |
| Lots covered | Usually one extract per run | Several independent lots by design |
| Best use | Method development and troubleshooting: choosing retention and cleanup | Quantifying the effect and its variability |
| Regulated role | Development evidence | Feeds the lot-based QC evaluation in ICH M10 section 3.2.3 |
Nor does the trace say what caused a dip. If plasma or serum extracts are involved, monitoring lipid-class signals is a separate experiment, covered in the guide to phospholipid interference in LC-MS/MS.
How do you use the infusion map to fix a matrix effect?
There are two routes: separate the analyte from the material that causes the effect, or remove that material before injection. Figure 2 shows both, with the map acquired again after each change.
Chromatographic changes move matrix components as well as the analyte, and not by the same amount. In Figure 2B the analyte moved 0.90 min and the suppression region 0.25 min; the old map would have predicted the wrong outcome, so the infusion is repeated under the new conditions. Cleanup works differently: Bonfiglio’s comparison showed that the extraction procedure changes how much suppressing material reaches the source,1 but a shallower region can still leave a residual effect, as in Figure 2C, where 12% suppression remains at the analyte’s retention time.
Whatever changes, check the internal standard too. The map is a function of retention time, so an internal standard that elutes even slightly away from the analyte samples a different part of it; a change that moves the analyte out of a dip can also move its internal standard, or a second analyte, into one. When the map looks clean, confirm the result quantitatively with post-extraction spikes across independent lots6 and, for regulated work, with the ICH M10 lot-based QC evaluation.7 If diluting the extract changes the calculated result, the dilution non-linearity diagnosis separates matrix effects from response-range and adsorption causes.
Can post-column infusion be used for routine monitoring or correction?
Post-column infusion is usually run only during method development or validation, but González and co-workers showed that infusing a set of standards continuously during routine analysis turns it into a quality-control tool. The infused signals exposed unexpected sources of matrix effect, supported the evaluation of sample treatments and tracked instrument performance within a batch, including variability between QC replicates and loss of sensitivity over time.5 A falling infused signal across a batch points at the instrument rather than at individual samples, which is the question the LC-MS sensitivity loss checklist works through.
Infusion can also be used for correction. Dubbelman and co-workers quantified eight endocannabinoids and related metabolites in plasma using the signal ratio to a post-column infused standard, selected against seven characteristics. The correction brought matrix effect, precision and dilutional linearity within acceptable ranges for at least six of the analytes, and it made plasma and neat-solution calibration curves parallel for six of the eight.8 That is one method in one matrix; the approach has to be selected, optimized and validated for each application, and it does not remove the need to show that the method meets its acceptance criteria.
Frequently asked questions
Which compound should I infuse for a post-column infusion experiment?
Infuse the analyte itself where you can. Matrix effects are compound-dependent, so a map made with an unrelated compound can show dips that do not affect your analyte or miss ones that do. Where several analytes share a method, infuse each one or a mixture monitored on separate transitions, and include the internal standard. If the analyte cannot be used, choose a compound with similar physicochemical properties, as González and co-workers recommend for infused standards (ref. 5). Record the infused compound and its concentration with the trace, because a map is only valid for what was infused.
Why do I need a solvent-blank injection as well as a matrix injection?
The solvent blank is the reference that tells you what the infused signal does when nothing from the matrix is present. Without it, any change in the infused signal during the run would be read as a matrix effect. Comparing the blank-matrix trace with the solvent trace at the same retention time, or dividing one by the other, isolates the part of the change caused by the extract. The comparison is made within the precision of the MS signal (ref. 4), so run the solvent blank close in time to the matrix injection and under identical conditions.
Does a flat post-column infusion trace prove there is no matrix effect?
No. A flat trace shows that one extracted lot produced no detectable change in one infused compound’s signal under one set of conditions. It does not measure the size of any effect or cover other lots, hemolyzed or lipemic samples or special populations. It may also not represent an analyte that ionizes differently from the infused compound. Treat a clean map as a reason to proceed to the quantitative experiment, the post-extraction spike across independent lots (ref. 6), not as the end of the assessment.
Is post-column infusion required by ICH M10?
The matrix-effect evaluation in ICH M10 section 3.2.3 is defined in terms of QC samples: at least three replicates of low and high QCs, each prepared in matrix from at least six sources or lots, with accuracy within ±15% of nominal and precision within 15% CV for each lot (ref. 7). The guideline does not mention post-column infusion. It is development evidence that helps you design a method that will pass that evaluation. It shows where to place analytes and whether a cleanup change helped, but it does not replace the lot-based QC experiment in a regulated validation.
How often should I repeat the infusion map?
Repeat it whenever something that controls retention or extract composition changes: the column, the gradient or mobile phase, the extraction procedure, the injection volume or the matrix type. Each of these can move matrix components relative to the analyte or change how much of them reaches the source, so an old map may no longer apply. Continuous infusion during routine batches, as described by González and co-workers (ref. 5), extends the idea from a one-off development experiment to ongoing monitoring of sample treatment and instrument performance.
Can post-column infusion replace a stable-isotope-labeled internal standard?
Not by default. Dubbelman and co-workers showed that correcting with a post-column infused standard improved matrix effect, precision and dilutional linearity for most analytes in one plasma method, and for six of eight analytes gave higher calibration accuracy than correction with their stable-isotope-labeled internal standards (ref. 8). That result depended on selecting and optimizing the infused standard for that method. For a new method, treat infused-standard correction as an option to be developed and validated, not as a drop-in substitute.
The takeaway
Post-column infusion answers one question well: at which retention times does this extract change the ionization of this compound. Run it with a solvent-blank reference, read the ratio across each analyte’s and internal standard’s window rather than at the deepest dip and use the map to decide whether to move the analyte or clean up the extract. Then acquire the map again, because chromatographic changes move matrix components too, and finish with the quantitative, lot-based experiment that the map cannot replace.
References
- R. Bonfiglio, R. C. King, T. V. Olah, K. Merkle, “The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds,” Rapid Commun. Mass Spectrom. 13(12), 1175–1185 (1999).
- F. T. Peters, D. Remane, “Aspects of matrix effects in applications of liquid chromatography–mass spectrometry to forensic and clinical toxicology—a review,” Anal. Bioanal. Chem. 403(8), 2155–2172 (2012).
- R. King, R. Bonfiglio, C. Fernandez-Metzler, C. Miller-Stein, T. Olah, “Mechanistic investigation of ionization suppression in electrospray ionization,” J. Am. Soc. Mass Spectrom. 11(11), 942–950 (2000).
- University of Tartu, “5.3 Qualitative estimation of matrix effect,” Validation of liquid chromatography mass spectrometry (LC-MS) methods (online course), sisu.ut.ee, accessed 30 September 2026.
- O. González, A.-C. Dubbelman, T. Hankemeier, “Postcolumn infusion as a quality control tool for LC-MS-based analysis,” J. Am. Soc. Mass Spectrom. 33(6), 1077–1080 (2022).
- B. K. Matuszewski, M. L. Constanzer, C. M. Chavez-Eng, “Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC–MS/MS,” Anal. Chem. 75(13), 3019–3030 (2003).
- International Council for Harmonisation, ICH M10: Bioanalytical Method Validation and Study Sample Analysis, Step 4 (24 May 2022), section 3.2.3 Matrix effect.
- A.-C. Dubbelman, B. van Wieringen, L. Roman Arias, M. van Vliet, R. Vermeulen, A. C. Harms, T. Hankemeier, “Strategies for using postcolumn infusion of standards to correct for matrix effect in LC-MS-based quantitative metabolomics,” J. Am. Soc. Mass Spectrom. 35(12), 3286–3295 (2024).
Further reading
- H. Trufelli, P. Palma, G. Famiglini, A. Cappiello, “An overview of matrix effects in liquid chromatography–mass spectrometry,” Mass Spectrom. Rev. 30(3), 491–509 (2011).
- A. Van Eeckhaut, K. Lanckmans, S. Sarre, I. Smolders, Y. Michotte, “Validation of bioanalytical LC–MS/MS assays: evaluation of matrix effects,” J. Chromatogr. B 877(23), 2198–2207 (2009).
- T. M. Annesley, “Ion suppression in mass spectrometry,” Clin. Chem. 49(7), 1041–1044 (2003).
Reviewed against primary sources. Every equation, definition and threshold on this page is checked against ICH M10 and the primary literature cited above. Numerical examples are illustrative calculations from the equations and conceptual traces stated and are not acceptance criteria. For validated or compendial methods, the applicable procedure and regulatory framework take precedence over the general rules of thumb given here. Evidence review: September 2026.